Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iBionext is a French venture capital firm and startup studio that specializes in the creation and development of innovative healthcare companies. Established in 2015, the firm focuses on high-potential technologies in the fields of biotechnology, medical devices, and digital health. iBionext employs a unique "Network" model, providing its portfolio companies with a collaborative environment, shared resources, and strategic expertise to accelerate clinical development. The firm's portfolio includes notable companies such as GenSight Biologics, Tissium, and BrainEver, targeting areas like ophthalmology and neurodegenerative diseases. By bridging the gap between academic research and industrial application, iBionext aims to bring transformative therapies to patients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iBionext Network.